journal article·2015-09

Optimized in vitro procedure for assessing the cytocompatibility of magnesium-based biomaterials

Ole Jung, Ralf Smeets, Dario Porchetta, Alexander Kopp, Christoph Ptock, Ute Müller, Max Heiland, Max Schwade, Björn Behr, Nadja Kröger, Lan Kluwe, Henning Hanken, Philip Hartjen

Acta Biomaterialia· Volume 23
Publisher page

Abstract

Magnesium (Mg) is a promising biomaterial for degradable implant applications that has been extensively studied in vitro and in vivo in recent years. In this study, we developed a procedure that allows an optimized and uniform in vitro assessment of the cytocompatibility of Mg-based materials while respecting the standard protocol DIN EN ISO 10993-5:2009. The mouse fibroblast line L-929 was chosen as the preferred assay cell line and MEM supplemented with 10% FCS, penicillin/streptomycin and 4mM l-glutamine as the favored assay medium. The procedure consists of (1) an indirect assessment of effects of soluble Mg corrosion products in material extracts and (2) a direct assessment of the surface compatibility in terms of cell attachment and cytotoxicity originating from active corrosion processes. The indirect assessment allows the quantification of cell-proliferation (BrdU-assay), viability (XTT-assay) as well as cytotoxicity (LDH-assay) of the mouse fibroblasts incubated with material extracts. Direct assessment visualizes cells attached to the test materials by means of live-dead staining. The colorimetric assays and the visual evaluation complement each other and the combination of both provides an optimized and simple procedure for assessing the cytocompatibility of Mg-based biomaterials in vitro.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Corrosion Behavior and Inhibition · Hydrogen Storage and Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
2. Surface modification of magnesium alloys developed for bioabsorbable orthopedic implants: a general review10.1002/jbm.b.32707 ↗
3. Future of local bone regeneration – protein versus gene therapy10.1016/j.jcms.2010.03.016 ↗
4. Current trends and future perspectives of bone substitute materials – from space holders to innovative biomaterials10.1016/j.jcms.2012.01.002 ↗
5. Tissue engineering technology and its possible applications in oral and maxillofacial surgery10.1016/j.bjoms.2013.03.005 ↗
6. Magnesium. An update on physiological, clinical and analytical aspects10.1016/S0009-8981(99)00258-2 ↗
7. Effects of SiO, SrO, MgO, and ZnO dopants in tricalcium phosphates on osteoblastic Runx2 expression
8. Degradation and antibacterial properties of magnesium alloys in artificial urine for potential resorbable ureteral stent applications10.1002/jbm.a.34741 ↗
9. Increased new bone formation with a surface magnesium-incorporated deproteinized porcine bone substitute in rabbit calvarial defects10.1002/jbm.a.34017 ↗
10. In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus10.1016/j.actbio.2009.10.007 ↗
11. Antibacterial biodegradable Mg–Ag alloys10.22203/eCM.v025a20 ↗
12. Revolutionizing orthopaedic biomaterials: the potential of biodegradable and bioresorbable magnesium-based materials for functional tissue engineering10.1016/j.jbiomech.2013.12.003 ↗
13. In vivo corrosion of four magnesium alloys and the associated bone response10.1016/j.biomaterials.2004.09.049 ↗
14. In vivo degradation performance of micro-arc-oxidized magnesium implants: a micro-CT study in rats10.1016/j.actbio.2012.09.017 ↗
15. A review of magnesium/magnesium alloys corrosion and its protection10.2174/1877610801002010013 ↗
16. Critical discussion of the results from different corrosion studies of Mg and Mg alloys for biomaterial applications10.1016/j.actbio.2009.12.048 ↗
17. Biodegradable magnesium alloys: a review of material development and applications10.4028/www.scientific.net/JBBTE.12.25 ↗
18. In vitro studies of biomedical magnesium alloys in a simulated physiological environment: a review10.1016/j.actbio.2010.12.004 ↗
19. Interference of magnesium corrosion with tetrazolium-based cytotoxicity assays10.1016/j.actbio.2009.10.020 ↗
20. Understanding magnesium corrosion – a framework for improved alloy performance10.1002/adem.200310405 ↗
21. Degradation behaviour of pure magnesium in simulated body fluids with different concentrations of HCO3−10.1016/j.corsci.2011.01.015 ↗
22. Effect of pH on the in vitro corrosion rate of magnesium degradable implant material10.1016/j.msec.2010.04.003 ↗
23. In vitro and in vivo assessment of the biocompatibility of an Mg-6Z(n) alloy in the bile10.1007/s10856-013-5090-3 ↗
24. Investigation of magnesium–zinc–calcium alloys and bone marrow derived mesenchymal stem cell response in direct culture10.1016/j.actbio.2014.10.018 ↗
25. In vitro degradation and cytotoxicity response of Mg-4% Zn-0.5% Zr (ZK40) alloy as a potential biodegradable material10.1016/j.actbio.2013.07.001 ↗
26. Biodegradable CaMgZn bulk metallic glass for potential skeletal application10.1016/j.actbio.2011.04.027 ↗
27. Reprint of: improved cytotoxicity testing of magnesium materials10.1016/j.mseb.2011.06.002 ↗
28. An investigation of the corrosion mechanisms of WE43 Mg alloy in a modified simulated body fluid solution: the influence of immersion time10.1016/j.corsci.2014.07.015 ↗
29. Magnesium alloys: predicting in vivo corrosion with in vitro immersion testing10.1002/jbm.b.32680 ↗
30. Cell death assays for drug discovery10.1038/nrd3373 ↗